Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 669, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-11-03
DOI
10.1126/scitranslmed.abj1270
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies
- (2022) Beatrice Greco et al. Science Translational Medicine
- Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
- (2022) David J. Friedman et al. JOURNAL OF IMMUNOLOGY
- Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
- (2022) Jinyu Wang et al. Frontiers in Cell and Developmental Biology
- Targeting glyco-immune checkpoints for cancer therapy
- (2021) Michela Manni et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
- (2021) Ernesto Rodriguez et al. Nature Communications
- Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity
- (2021) Itziar Ibarlucea-Benitez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses
- (2021) David J. Friedman et al. Cancer Immunology Research
- Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells
- (2021) Landon J. Edgar et al. ACS Central Science
- Siglecs as Immune Cell Checkpoints in Disease
- (2020) Shiteng Duan et al. Annual Review of Immunology
- Durable and controlled depletion of neutrophils in mice
- (2020) Gael Boivin et al. Nature Communications
- Targeted glycan degradation potentiates the anticancer immune response in vivo
- (2020) Melissa A. Gray et al. Nature Chemical Biology
- A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer
- (2019) Lucia D’Amico et al. Journal for ImmunoTherapy of Cancer
- Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing
- (2019) Satoshi Uchiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
- (2019) John V. Pluvinage et al. NATURE
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
- (2019) Stefan Mereiter et al. CANCER CELL
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity
- (2018) Christian Büll et al. CANCER RESEARCH
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clustering trees: a visualisation for evaluating clusterings at multiple resolutions
- (2018) Luke Zappia et al. GigaScience
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
- (2018) Funda Meric-Bernstam et al. CLINICAL CANCER RESEARCH
- Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis
- (2018) Lenneke A.M. Cornelissen et al. INTERNATIONAL JOURNAL OF CANCER
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- Viewing Siglecs through the lens of tumor immunology
- (2017) Isabella Fraschilla et al. IMMUNOLOGICAL REVIEWS
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
- (2016) Maurizio Perdicchio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells
- (2016) Maurizio Perdicchio et al. Oncotarget
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- The Emerging Understanding of Myeloid Cells as Partners and Targets in Tumor Rejection
- (2015) M. L. Broz et al. Cancer Immunology Research
- Systemic Blockade of Sialylation in Mice with a Global Inhibitor of Sialyltransferases
- (2014) Matthew S. Macauley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
- (2014) Heinz Läubli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Critical Roles of a Dendritic Cell Subset Expressing a Chemokine Receptor, XCR1
- (2013) C. Yamazaki et al. JOURNAL OF IMMUNOLOGY
- Structural Feature Ions for Distinguishing N- and O-Linked Glycan Isomers by LC-ESI-IT MS/MS
- (2013) Arun V. Everest-Dass et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans
- (2012) Arun V Everest-Dass et al. GLYCOBIOLOGY
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
- (2011) Y.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes
- (2010) H. M. Meesmann et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More